Morgan M H, Bolton C H, Morris J S, Read A E
Gut. 1974 Mar;15(3):180-4. doi: 10.1136/gut.15.3.180.
The oral administration of short (C(6)) and medium (C(8) and (C(10)) chain triglycerides produced no clinical or electroencephalographic changes in patients with cirrhosis of the liver. Arterial ammonia levels were also monitored in these patients and showed no significant change after medium chain triglycerides. It was concluded that medium chain triglycerides, known to be of potential value in the treatment of malabsorption in patients with cirrhosis, are not clinically contraindicated, even in patients with evidence of hepatic encephalopathy.
对肝硬化患者口服短链（C6）和中链（C8和C10）甘油三酯后，未观察到临床或脑电图变化。同时对这些患者的动脉血氨水平进行了监测，结果显示服用中链甘油三酯后无显著变化。得出的结论是，已知中链甘油三酯在治疗肝硬化患者吸收不良方面具有潜在价值，即使对有肝性脑病迹象的患者，临床上也没有禁忌。
